סינטרום
novartis pharma services ag - acenocoumarol 4 mg - tablets - acenocoumarol - anticoagulant derived from coumarin.
מיקרופירין 100
dexcel ltd - acetylsalicylic acid 100 mg - tablets enteric coated - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
קרדיופירין
dexcel ltd - acetylsalicylic acid 100 mg - tablets enteric coated - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
גרמזה פירין 325 מ"ג
gramse pharmaceuticals ltd - acetylsalicylic acid 325 mg - tablets enteric coated - acetylsalicylic acid - analgetic,antipyretic.
הקסאקפרון 500 מ"ג
teva pharmaceutical indust.ltd - tranexamic acid 500 mg - tablets - tranexamic acid - treatment of hemorrhage occuring in some forms of surgery, including prostatectomy. hematuria. menorrhagia. hereditary angioneurotic edema.
אמיוקור 200 מ"ג
taro pharmaceutical industries ltd - amiodarone hydrochloride 200 mg - tablets - amiodarone - for the treatment of life-threatening recurrent ventricular arrhythmias and coronary insufficiency.
מונוניט 20
perrigo israel pharmaceuticals ltd - isosorbide mononitrate 20 mg - tablets - isosorbide mononitrate - prophylactic treatment of angina pectoris. treatment of congestive heart failure.
רנקסה 1000 מ"ג
neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
רנקסה 1000 מ"ג
neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
רנקסה 500 מ"ג
neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.